COMMUNIQUÉS West-GlobeNewswire

Alumis Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
09/01/2026
SOUTH SAN FRANCISCO, Calif., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Alumis Inc. (Nasdaq: ALMS), a clinical-stage biopharmaceutical company developing next-generation targeted therapies for patients with immune-mediated [...]
La Croix-Rouge canadienne sollicite des dons afin de bonifier le soutien offert aux personnes touchées par la crise dans la Nation crie de Pimicikamak
09/01/2026
WINNIPEG, 09 janv. 2026 (GLOBE NEWSWIRE) -- La Croix-Rouge canadienne a mis sur pied le Fonds de secours : Crise de 2026 dans la Nation crie de Pimicikamak pour venir en aide aux personnes touchées par la panne de [...]
Canadian Red Cross opens appeal to expand support for the Pimicikamak Cree Nation Crisis
09/01/2026
WINNIPEG, Jan. 09, 2026 (GLOBE NEWSWIRE) -- The Canadian Red Cross has launched the 2026 Pimicikamak Cree Nation Crisis Appeal to provide support for those impacted by the power outage in Pimicikamak Cree Nation, [...]
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
09/01/2026
CAMBRIDGE, Mass., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with [...]
U.S. Neurology Associates Partners with M33 Growth to Transform Neurological Care
09/01/2026
DALLAS and BOSTON, Jan. 09, 2026 (GLOBE NEWSWIRE) -- M33 Growth, a Boston-based venture and growth-stage investment firm, today announced its partnership with U.S. Neurology Associates (“USNA” or the “Company”), a [...]
Cooper Aerobics Partners with The Stayton at Museum Way
09/01/2026
Wellness Center Management & Wellness Programming by Cooper DALLAS and FORT WORTH, Texas, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Cooper Wellness Strategies (CWS), a Cooper Aerobics company, expands its partnership with [...]
Ascendis Pharma Provides Business and Strategic Roadmap Update at 44th Annual J.P. Morgan Healthcare Conference
10/01/2026
- Rapidly transforming into a leading global biopharma company COPENHAGEN, Denmark, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today provided a business and strategic roadmap update, including [...]
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
09/01/2026
BRISBANE, Calif., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that, on January 5, 2026, the Compensation Committee of the Board of Directors of Vera Therapeutics granted [...]
Most Popular SARMS for Bulking, Muscle Building and Strength 2026: Latest SARM Stacks for Muscle Growth & Bodybuilding - CrazyBulk
09/01/2026
Best SARM for muscle growth and strength for 2026 from leading supplement company CrazyBulk - which SARMS stack is best for bulking cycles and faster recovery" New York City,, Jan. 09, 2026 (GLOBE NEWSWIRE) -- "SARMs [...]
China SXT Pharmaceuticals Inc. Announces $10 Million Registered Direct Offering
09/01/2026
TAIZHOU, China, Jan. 09, 2026 (GLOBE NEWSWIRE) -- China SXT Pharmaceuticals Inc. (NASDAQ: SXTC) (the “Company”), today announced that it has entered into a definitive agreement with a single investor for the purchase [...]
Gastro Center of Maryland Expands Columbia Team with New Board-Certified Gastroenterologists
09/01/2026
COLUMBIA, Md., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Gastro Center of Maryland is pleased to announce the addition of new board-certified gastroenterologists to its Columbia location at 7120 Minstrel Way, Suite 100. This [...]
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
09/01/2026
BOSTON, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous [...]
Novartis to add radioligand therapy manufacturing facility in Winter Park, Florida, fourth in US to serve patients and advance $23 billion investment
09/01/2026
New 35,000-square-foot facility in Winter Park will expand RLT manufacturing footprint to optimize delivery for patients across southeastern US Purpose-built facility will strengthen Novartis RLT manufacturing network [...]
Novartis to add radioligand therapy manufacturing facility in Winter Park, Florida, fourth in US to serve patients and advance $23 billion investment
09/01/2026
New 35,000-square-foot facility in Winter Park will expand RLT manufacturing footprint to optimize delivery for patients across southeastern US Purpose-built facility will strengthen Novartis RLT manufacturing network [...]
SEED Therapeutics Doses First Patient in Phase 1 Trial of ST-01156, a Molecular Glue Degrader Targeting RBM39
09/01/2026
First-in-human study evaluates safety, pharmacokinetics, biomarker analyses, target engagement, and anti-tumor activity in patients with advanced solid tumors ST-01156 has received U.S. FDA Orphan Drug Designation and [...]
Angels My Way Home Care Celebrates 15th 5-Star Google Review, Reinforcing Role as Best Home Health Care Service in Hamilton, Ontario
09/01/2026
Angels My Way Home Care continues to set the standard for excellence in home health care services with its latest milestone. Hamilton, Ontario, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Angels My Way Home Care , a leading [...]
Fortrea Announces Updated Presentation Time at Upcoming J.P. Morgan Healthcare Conference
09/01/2026
DURHAM, N.C., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced an updated presentation time of 11:15 am PST on Tuesday, January 13, 2026, [...]
Disclosure of notification received from BNP Paribas
09/01/2026
Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 09 January 2026 – 5:40 PM CET Disclosure of notification received from BNP Paribas Pursuant to the Belgian law of 2 May 2007 regarding the disclosure [...]
Bright Minds Biosciences Announces Closing of US$175 Million Public Offering
09/01/2026
NEW YORK, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (CSE: DRUG) (NASDAQ: DRUG) (“ Bright Minds ” or the “ Company ”) today closed its recently announced public offering of 1,945,000 common shares [...]

Pages